Raymond James Financial
OGN icon

Raymond James Financial’s Organon & Co OGN Stock Holding History

Raymond James Financial’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,400
Closed -$212K – 5410
2025
Q4 		$212K Buy
+35,400
New +$280K ﹤0.01% 4759

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Raymond James Financial's OGN Position: Q2 2026 in Review

Raymond James Financial reduced its Organon & Co (OGN) stake by 35% in Q2 2026, selling an estimated $1.36M and leaving 214,341 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3221.

Raymond James Financial first reported a position in OGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.74M in Q1 2025. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Raymond James Financial held 214,341 shares of Organon & Co worth $2.9M as of Q2 2026.
  • Raymond James Financial sold 113,594 Organon & Co shares in Q2 2026, an estimated $1.36M.
  • Organon & Co made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3221 holding.
  • Raymond James Financial first reported a position in Organon & Co in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Organon & Co position peaked at $4.74M in Q1 2025.
  • 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.